FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Sumitomo Gets Fast Track Status for Nuvisertib

[ Price : $8.95]

FDA grants Sumitomo Pharma America a fast track designation for nuvisertib (TP-3654) and its use in treating patients with interme...

CDC, NIH Staff Protest Trump Administration Chaos

[ Price : $8.95]

Current and former CDC employees rally outside the agencys Atlanta headquarters yesterday over Trump Administration-inspired chaos...

Amish Origins Marketing Unapproved Drugs: FDA

[ Price : $8.95]

FDA warns Worland, WY-based Amish Origins Management about CGMP violations in its manufacturing of unapproved and misbranded drug ...

FY 2024 Real-World Evidence Statistics Out

[ Price : $8.95]

FDA publishes statistics on real-world evidence submissions to CBER and CDER in FY 2024 compared to the previous year.

Bayesian Demo Project Explained

[ Price : $8.95]

FDA posts an online notice explaining CDERs Bayesian Statistical Analysis demonstration project.

Government Drug Price Listening Sessions

[ Price : $8.95]

The Federal Trade Commission and Justice Department announce three live-streamed listening sessions on aspects of the effort to cu...

AbbVie Gains Expanded Label on Hep C Drug

[ Price : $8.95]

FDA approves an AbbVie expanded label for Mavyret (glecaprevir/pibrentasvir) to include treating adults and pediatric patients thr...

Nuvation Lung Cancer Drug Ibtrozi Approved

[ Price : $8.95]

FDA approves a Nuvation Bio NDA for Ibtrozi (taletrectinib), a kinase inhibitor for adults with locally advanced or metastatic ROS...

FDA to Tweak Industry/Reviewer Communications: Makary

[ Price : $8.95]

FDA commissioner Marty Makary says the agency will improve the communication channels between reviewers and companies to help spee...

FDA Grants, Denies Fenofribrate Petition

[ Price : $8.95]

FDA says it has made labeling changes to fenofibrates as requested in a Healthy Women petition and does not see a need for additio...